With 40% Stake, Sera Prognostics, Inc. (NASDAQ:SERA) Seems to Have Captured Institutional Investors' Interest

Yahoo FinanceDec 19 19:13

Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting

PR NewswireDec 5 05:01

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PR NewswireNov 15 21:30

Have Sera Prognostics Insiders Been Selling Stock?

Simply Wall StNov 15 19:56

TD Cowen Maintains Sera Prognostics(SERA.US) With Buy Rating

Futu NewsNov 9 06:31 · Ratings

TD Cowen Reaffirms Their Buy Rating on Sera Prognostics (SERA)

TipRanksNov 9 05:55